Formulation and Evaluation of Bilayer Tablets of Metoclopramide Hydrochloride and Diclofenac Sodium

References

1. 1.↵
   1. Lieberman A. H.

   1. Gunsel W. C.

   Compression-coated and layer tablet. In Pharmaceutical Dosage Forms: Tablets, Lieberman A. H. Ed.; Marcel Decker Inc.: New York, 1989; p 274– 284.
2. 2.↵
   1. Shiyani B.,
   2. Gattani S.,
   3. Surana S.

   Formulation and evaluation of bi-layer tablet of metoclopramide hydrochloride and ibuprofen. AAPS PharmSciTech. 2008, 9 (3), 818–827.

   OpenUrlPubMed
3. 3.↵
   1. Wells B. G.,
   2. Dipiro J. T.,
   3. Schwinghammer T. L.,
   4. Hamilton C. W.

   Pharmacotherapy Handbook; McGraw-Hill: New York, 2006.
4. 4.↵
   1. Brittain H. G.

   1. Pitre D.,
   2. Stradi R.

   Metoclopromide HCl. In Analytical Profiles of Drug Substances and Excipients, Brittain H. G. Ed.; Elsevier Academic Press: New Delhi, India, 2001; pp 326– 360.
5. 5.↵
   1. Brittain H. G.

   1. Adeyeye C. M.,
   2. Li P.-K.

   Diclofenac Sodium. In Analytical Profiles of Drug Substances and Excipients, Brittain H. G. Ed.; Elsevier Academic Press: New Delhi, India, 2001; pp 123– 144.
6. 6.↵
   1. Sweetman S. C.

   Martindale, The Complete Drug Reference, 33rd ed, Sweetman S. C. Ed.; Pharmaceutical Press: London, 2002.
7. 7.↵
   1. Hardman J. G.,
   2. Limbird L. E.

   Goodman and Gillman's, The Pharmacological Basis of Therapeutics, 9th ed., Hardman J. G., Limbird L. E. Eds.; McGraw Hill Company: New York, 1996 [CD-ROM].
8. 8.↵
   1. Bagul U. S.,
   2. Bagul N. S.,
   3. Kulkarni M. S.,
   4. Swant S. D.,
   5. Gujar N. K.,
   6. Bidkar A. A.

   Current status of tablet disintegrants: a review. Pharm. Rev. 2006, 4 (4).
9. 9.↵
   1. Açıkgöz M.,
   2. Kaş H. S.,
   3. Hıncal A. A.

   Diclofenac sodium, bioavailability file, FABAD, Far. Bil. Der. 1994, 19 (1): 37– 47.

   OpenUrl
10. 10.↵
    1. Parikh D. M.

    1. Heng P. W.,
    2. Chah L. W.

    Drug substance and excipient characterization. In Handbook of Pharmaceutical Granulation Technology, Parikh D. M. Ed.; Marcel Decker: New York, 1997; pp 52–55.
11. 11.↵
    1. Ohwoavworhua F.,
    2. Adelakun T.

    Phosphoric acid–mediated depolymerization and decrystallization of α-cellulose obtained from corn cob: preparation of low crystallinity cellulose and some physicochemical properties. Trop. J. Pharm. Res. 2004, 4, 509– 516.

    OpenUrl
12. 12.↵
    1. Reddy K. R.,
    2. Mutalik S.,
    3. Reddy S.

    Once-daily sustained-release matrix tablets of nicorandil: formulation and in vitro evaluation. AAPS PharmSciTech. 2003, 4, 1– 9.

    OpenUrl
13. 13.↵
    1. Wells J. I.

    Pharmaceutical Preformulation: The physicochemical properties of drug substances; John Wiley and Sons: New York, 1988.
14. 14.↵
    USP/NF. Physical Tests: Disintegration 〈701〉. In USP22 NF 17, U.S. Pharmacopeial Convention, Inc.: Rockville, MD, 1990.
15. 15.↵
    Indian Pharmacopoeia; Controller of Publication: New Delhi, India, 1996.
16. 16.↵
    1. Mutasem M.,
    2. Rawas Q.

    Fast-disintegrating sublingual tablets: effect of epinephrine load on tablet characteristics. AAPS PharmSciTech. 2006, 7, E1–E7.

    OpenUrlPubMed
17. 17.↵
    1. Zhao N.,
    2. Augsburger L. L.

    Functional comparison of 3 classes of disintegrants in promoting aspirin tablet disintegration and dissolution. AAPS PharmSciTech. 2005, 6, E634– E640.

    OpenUrlPubMed
18. 18.↵
    1. Merchant H. A.,
    2. Shoaib H. M.,
    3. Tazeen J.,
    4. Yousuf R. I.

    Once-daily tablet formulation and in vitro release evaluation of cefpodoxime using hydroxypropyl methylcellulose: a technical note. AAPS PharmSciTech 2006, 7, E1–E6.

    OpenUrlPubMed
19. 19.↵
    1. Rao K. V.,
    2. Devi K. P.,
    3. Buri P.

    Influence of molecular size and water solubility of the solute on its release from swelling and erosion controlled polymeric matrices. J. Controlled Release 1996, 12, 133– 141.

    OpenUrl
20. 20.↵
    1. Avachat A.,
    2. Kotwal V.

    Design and evaluation of matrix based controlled release tablets of diclofenac Na and chondritin sulphate. AAPS PharmSciTech. 2007, 8, E1– E6.

    OpenUrl
21. 21.↵
    1. Baykara T.

    Effect of direct tabletting agents on drug release kinetics and swelling behavior of hydrophilic matrix tablets. Turk. J. Med. Sci. 2006, 36, 177– 184.

    OpenUrl